Two of those — Reps. The KHN analysis shows that pharmaceutical companies tend to play the field, giving to a wide swath of lawmakers on both sides of the aisle. The mney industry favors power. Since the beginning ofdrugmakers contributed to Republicans and Democrats, giving only slightly more on average to Republicans, who currently control both chambers of Congress. This was also the case for Democrats during the election cycle, when they controlled Congress. As with other industries, drugmakers tend to give more to lawmakers in leadership roles. For example, Rep. Money also tends to flow to congressional committees with jurisdiction over pharmaceutical issues that can affect things like drug pricing and FDA approval.